BIGG

Início > Guias GRADE > Resultado da busca

Resultados: 5

Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): 20-valent pneumococcal conjugate vaccine (PCV20) for children aged 2 through 18 years with underlying medical conditions

MMWR recomm. rep; 72 (39), 2023
On June 22, 2023, the CDC’s Advisory Committee on Immunization Practices (ACIP) recommended use of 20-valent pneumococcal conjugate vaccine (PCV20 [Prevnar 20, Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.]) as an option to 15-valent pneumococcal conjugate vaccine (PCV15 [Vaxneuvance, Merck Sh...
Vacina Pneumocócica Conjugada Heptavalente/uso terapêutico, Infecções Pneumocócicas/prevenção & controle, Imunogenicidade da Vacina, Comorbidade
Texto completo

Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): 20-valent pneumococcal conjugate vaccine (PCV20) for children aged <2 years

MMWR recomm. rep; 72 (39), 2023
On June 22, 2023, the CDC’s Advisory Committee on Immunization Practices (ACIP) recommended use of 20-valent pneumococcal conjugate vaccine (PCV20 [Prevnar 20, Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.]) as an option to 15-valent pneumococcal conjugate vaccine (PCV15 [Vaxneuvance, Merck Sh...
Vacina Pneumocócica Conjugada Heptavalente/uso terapêutico, Infecções Pneumocócicas/prevenção & controle, Imunogenicidade da Vacina
Texto completo

Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): 20-valent pneumococcal conjugate vaccine (PCV20) use among adults aged 19–64 years with an immunocompromising condition, cerebrospinal fluid leak, or cochlear implant who previously received a 13-valent pneumococcal conjugate vaccine (PCV13)

MMWR recomm. rep; 72 (3), 2023
On October 19, 2022, the U.S. Advisory Committee on Immunization Practices (ACIP) recommended the use of either a dose of 20-valent pneumococcal conjugate vaccine (PCV20) or 23-valent pneumococcal polysaccharide vaccine (PPSV23) as previously recommended for adults who have received 13-valent pneumococca...
Vacina Pneumocócica Conjugada Heptavalente/imunologia, Hospedeiro Imunocomprometido, Implante Coclear, Vazamento de Líquido Cefalorraquidiano
Texto completo

Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): 20-valent pneumococcal conjugate vaccine (PCV20) use among adults aged ≥65 years who previously received a 13-valent pneumococcal conjugate vaccine (PCV13)

MMWR recomm. rep; 72 (3), 2023
On October 19, 2022, the U.S. Advisory Committee on Immunization Practices (ACIP) recommended the use of either a dose of 20-valent pneumococcal conjugate vaccine (PCV20) or 23-valent pneumococcal polysaccharide vaccine (PPSV23) as previously recommended for adults who have received 13-valent pneumococca...
Vacina Pneumocócica Conjugada Heptavalente, Programas de Imunização, Pneumonia Pneumocócica/imunologia
Texto completo

GRADE: 15-valent pneumococcal conjugate vaccine (PCV15) use in children aged <2 years

MMWR recomm. rep; 71 (37), 2022
On June 22, 2022, ACIP recommended use of 15-valent pneumococcal conjugate vaccine (PCV15 [Vaxneuvance, Merck Sharp & Dohme LLC]) as an option for pneumococcal conjugate vaccination for persons aged <19 years according to currently recommended PCV13 dosing and schedules. A systematic review and Grading o...
Infecções Pneumocócicas/imunologia, Vacina Pneumocócica Conjugada Heptavalente/uso terapêutico, Imunogenicidade da Vacina
Texto completo